Edition:
United Kingdom

Autolus Therapeutics PLC (AUTL.OQ)

AUTL.OQ on NASDAQ Stock Exchange Global Select Market

27.78USD
8:59pm GMT
Change (% chg)

$-0.20 (-0.71%)
Prev Close
$27.98
Open
$28.06
Day's High
$29.40
Day's Low
$26.51
Volume
8,291
Avg. Vol
16,335
52-wk High
$53.14
52-wk Low
$19.33

Chart for

About

Autolus Therapeutics plc, formerly Autolus Therapeutics Limited, is a development-stage biopharmaceutical company. The company is engaged in developing programmed T-cell therapies for the treatment of cancer. The Company's clinical-stage product candidates target hematological cancers. Its products candidates include AUTO2,... (more)

Overall

No Ratios Available.

Financials

  AUTL.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -- -- --
ROI: -- 8.92 14.45
ROE: -- 10.08 15.96

Earnings vs. Estimates